• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为动态系统的干细胞移植:临床结果是可确定的吗?

Stem cell transplantation as a dynamical system: are clinical outcomes deterministic?

作者信息

Toor Amir A, Kobulnicky Jared D, Salman Salman, Roberts Catherine H, Jameson-Lee Max, Meier Jeremy, Scalora Allison, Sheth Nihar, Koparde Vishal, Serrano Myrna, Buck Gregory A, Clark William B, McCarty John M, Chung Harold M, Manjili Masoud H, Sabo Roy T, Neale Michael C

机构信息

Stem Cell Transplant Program, Department of Internal Medicine, Massey Cancer Center, Virginia Commonwealth University , Richmond, VA , USA.

Center for the Study of Biological Complexity, Virginia Commonwealth University , Richmond, VA , USA.

出版信息

Front Immunol. 2014 Dec 3;5:613. doi: 10.3389/fimmu.2014.00613. eCollection 2014.

DOI:10.3389/fimmu.2014.00613
PMID:25520720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4253954/
Abstract

Outcomes in stem cell transplantation (SCT) are modeled using probability theory. However, the clinical course following SCT appears to demonstrate many characteristics of dynamical systems, especially when outcomes are considered in the context of immune reconstitution. Dynamical systems tend to evolve over time according to mathematically determined rules. Characteristically, the future states of the system are predicated on the states preceding them, and there is sensitivity to initial conditions. In SCT, the interaction between donor T cells and the recipient may be considered as such a system in which, graft source, conditioning, and early immunosuppression profoundly influence immune reconstitution over time. This eventually determines clinical outcomes, either the emergence of tolerance or the development of graft versus host disease. In this paper, parallels between SCT and dynamical systems are explored and a conceptual framework for developing mathematical models to understand disparate transplant outcomes is proposed.

摘要

干细胞移植(SCT)的结果是使用概率论进行建模的。然而,SCT后的临床过程似乎表现出动态系统的许多特征,特别是当在免疫重建的背景下考虑结果时。动态系统倾向于根据数学确定的规则随时间演变。其特点是,系统的未来状态取决于其之前的状态,并且对初始条件敏感。在SCT中,供体T细胞与受体之间的相互作用可被视为这样一个系统,其中移植物来源、预处理和早期免疫抑制随着时间的推移深刻影响免疫重建。这最终决定了临床结果,即耐受的出现或移植物抗宿主病的发展。在本文中,探讨了SCT与动态系统之间的相似之处,并提出了一个用于开发数学模型以理解不同移植结果的概念框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29cc/4253954/d2d5ab6a3e27/fimmu-05-00613-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29cc/4253954/20870babfbda/fimmu-05-00613-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29cc/4253954/dd56ad9fdd07/fimmu-05-00613-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29cc/4253954/a52fa11bf6dd/fimmu-05-00613-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29cc/4253954/d2d5ab6a3e27/fimmu-05-00613-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29cc/4253954/20870babfbda/fimmu-05-00613-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29cc/4253954/dd56ad9fdd07/fimmu-05-00613-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29cc/4253954/a52fa11bf6dd/fimmu-05-00613-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29cc/4253954/d2d5ab6a3e27/fimmu-05-00613-g004a.jpg

相似文献

1
Stem cell transplantation as a dynamical system: are clinical outcomes deterministic?作为动态系统的干细胞移植:临床结果是可确定的吗?
Front Immunol. 2014 Dec 3;5:613. doi: 10.3389/fimmu.2014.00613. eCollection 2014.
2
Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes.异基因干细胞移植后免疫重建的动态系统建模可识别出有不良结局风险的患者。
Biol Blood Marrow Transplant. 2015 Jul;21(7):1237-45. doi: 10.1016/j.bbmt.2015.03.011. Epub 2015 Apr 4.
3
Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.造血干细胞移植操作作为一种免疫治疗机制。
Int Immunopharmacol. 2003 Aug;3(8):1121-43. doi: 10.1016/S1567-5769(03)00014-6.
4
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
5
A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation.两步单倍体相合与两步匹配相关异基因清髓性外周血干细胞移植
Biol Blood Marrow Transplant. 2016 Jan;22(1):141-8. doi: 10.1016/j.bbmt.2015.09.017. Epub 2015 Sep 28.
6
Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.在进行非清髓性预处理后输注供体干细胞,以诱导对 HLA 不匹配的成人活体供肝移植的耐受性。
Transpl Immunol. 2004 Sep-Oct;13(2):139-46. doi: 10.1016/j.trim.2004.05.004.
7
Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens.采用减低剂量预处理方案的异基因干细胞移植后的免疫重建
Leukemia. 2007 Aug;21(8):1628-37. doi: 10.1038/sj.leu.2404681. Epub 2007 May 24.
8
Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis.两种标准的降低强度预处理方案和两种不同移植物来源在血液病成人患者异基因干细胞移植中的疗效比较:一项单中心分析。
Biol Blood Marrow Transplant. 2013 Jun;19(6):934-9. doi: 10.1016/j.bbmt.2013.03.009. Epub 2013 Mar 21.
9
Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation.减低强度预处理方案在造血干细胞移植后的早期可保留胸腺功能。
Exp Hematol. 2005 Oct;33(10):1240-8. doi: 10.1016/j.exphem.2005.06.016.
10
[Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].[捷克共和国慢性髓性白血病患者的异基因造血干细胞移植——1988 - 2005年结果的回顾性分析]
Vnitr Lek. 2006 Dec;52(12):1172-80.

引用本文的文献

1
T Cell Repertoire Evolution after Allogeneic Bone Marrow Transplantation: An Organizational Perspective.异基因骨髓移植后 T 细胞受体库的演变:组织学视角。
Biol Blood Marrow Transplant. 2019 May;25(5):868-882. doi: 10.1016/j.bbmt.2019.01.021. Epub 2019 Jan 21.
2
Determining the Quantitative Principles of T Cell Response to Antigenic Disparity in Stem Cell Transplantation.确定干细胞移植中抗原差异的 T 细胞反应的定量原则。
Front Immunol. 2018 Oct 11;9:2284. doi: 10.3389/fimmu.2018.02284. eCollection 2018.
3
Dynamical system modeling to simulate donor T cell response to whole exome sequencing-derived recipient peptides: Understanding randomness in alloreactivity incidence following stem cell transplantation.

本文引用的文献

1
In silico Derivation of HLA-Specific Alloreactivity Potential from Whole Exome Sequencing of Stem-Cell Transplant Donors and Recipients: Understanding the Quantitative Immunobiology of Allogeneic Transplantation.通过干细胞移植供体和受体的全外显子组测序进行HLA特异性同种异体反应性潜能的计算机推导:理解异基因移植的定量免疫生物学
Front Immunol. 2014 Nov 6;5:529. doi: 10.3389/fimmu.2014.00529. eCollection 2014.
2
Whole exome sequencing to estimate alloreactivity potential between donors and recipients in stem cell transplantation.全外显子组测序评估干细胞移植中供体与受者之间的同种异体反应潜能。
Br J Haematol. 2014 Aug;166(4):566-70. doi: 10.1111/bjh.12898. Epub 2014 Apr 18.
3
动态系统建模以模拟供体T细胞对全外显子组测序衍生的受体肽的反应:理解干细胞移植后同种异体反应发生率中的随机性。
PLoS One. 2017 Dec 1;12(12):e0187771. doi: 10.1371/journal.pone.0187771. eCollection 2017.
4
Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes.造血干细胞移植结果超出组织相容性基因的遗传关联。
Front Immunol. 2017 Apr 3;8:380. doi: 10.3389/fimmu.2017.00380. eCollection 2017.
5
On the organization of human T-cell receptor loci: log-periodic distribution of T-cell receptor gene segments.关于人类T细胞受体基因座的组织:T细胞受体基因片段的对数周期分布
J R Soc Interface. 2016 Jan;13(114):20150911. doi: 10.1098/rsif.2015.0911.
6
Dynamical System Modeling to Simulate Donor T Cell Response to Whole Exome Sequencing-Derived Recipient Peptides Demonstrates Different Alloreactivity Potential in HLA-Matched and -Mismatched Donor-Recipient Pairs.用于模拟供体T细胞对全外显子测序衍生的受体肽反应的动态系统建模显示,在HLA匹配和不匹配的供体-受体对中存在不同的同种异体反应性潜力。
Biol Blood Marrow Transplant. 2016 May;22(5):850-61. doi: 10.1016/j.bbmt.2015.11.1103. Epub 2015 Dec 11.
7
Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes.异基因干细胞移植后免疫重建的动态系统建模可识别出有不良结局风险的患者。
Biol Blood Marrow Transplant. 2015 Jul;21(7):1237-45. doi: 10.1016/j.bbmt.2015.03.011. Epub 2015 Apr 4.
8
In silico Derivation of HLA-Specific Alloreactivity Potential from Whole Exome Sequencing of Stem-Cell Transplant Donors and Recipients: Understanding the Quantitative Immunobiology of Allogeneic Transplantation.通过干细胞移植供体和受体的全外显子组测序进行HLA特异性同种异体反应性潜能的计算机推导:理解异基因移植的定量免疫生物学
Front Immunol. 2014 Nov 6;5:529. doi: 10.3389/fimmu.2014.00529. eCollection 2014.
Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation.
调节性 T 细胞和自然杀伤 T 细胞在异基因造血细胞移植后调节移植物抗宿主病。
Blood. 2013 Oct 31;122(18):3116-21. doi: 10.1182/blood-2013-08-453126. Epub 2013 Sep 25.
4
Fractal organization of the human T cell repertoire in health and after stem cell transplantation.人类 T 细胞库在健康状态和干细胞移植后的分形组织。
Biol Blood Marrow Transplant. 2013 Mar;19(3):366-77. doi: 10.1016/j.bbmt.2012.12.004. Epub 2013 Jan 11.
5
Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia.双份单位移植物成功地扩展了脐带血移植在急性白血病成人患者中的应用。
Blood. 2013 Jan 31;121(5):752-8. doi: 10.1182/blood-2012-08-449108. Epub 2012 Dec 9.
6
Immune reconstitution kinetics as an early predictor for mortality using various hematopoietic stem cell sources in children.使用各种造血干细胞来源预测儿童免疫重建动力学与死亡率的关系。
Biol Blood Marrow Transplant. 2013 Feb;19(2):305-13. doi: 10.1016/j.bbmt.2012.10.010. Epub 2012 Oct 22.
7
Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation.硼替佐米为基础的 HLA 不合无关供者移植移植物抗宿主病预防。
J Clin Oncol. 2012 Sep 10;30(26):3202-8. doi: 10.1200/JCO.2012.42.0984. Epub 2012 Aug 6.
8
Anti-thymocyte globulin for conditioning in matched unrelated donor hematopoietic cell transplantation provides comparable outcomes to matched related donor recipients.抗胸腺细胞球蛋白在非亲缘供者造血细胞移植预处理中提供了与亲缘供者受者相当的结果。
Bone Marrow Transplant. 2012 Dec;47(12):1513-9. doi: 10.1038/bmt.2012.81. Epub 2012 May 14.
9
The ever elusive permissive mismatch.难以捉摸的允许性错配。
Biol Blood Marrow Transplant. 2012 May;18(5):657-8. doi: 10.1016/j.bbmt.2012.03.006. Epub 2012 Mar 24.
10
Distinct oligoclonal T cells are associated with graft versus host disease after stem-cell transplantation.在干细胞移植后,独特的寡克隆 T 细胞与移植物抗宿主病有关。
Transplantation. 2012 May 15;93(9):949-57. doi: 10.1097/TP.0b013e3182497561.